Edition:
United States

OvaScience Inc (OVAS.OQ)

OVAS.OQ on NASDAQ Stock Exchange Global Market

0.93USD
22 Jun 2018
Change (% chg)

$-0.05 (-4.90%)
Prev Close
$0.98
Open
$0.98
Day's High
$0.98
Day's Low
$0.93
Volume
113,460
Avg. Vol
61,260
52-wk High
$1.96
52-wk Low
$0.71

Chart for

About

OvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's... (more)

Overall

Beta: 3.53
Market Cap(Mil.): $49.96
Shares Outstanding(Mil.): 35.69
Dividend: --
Yield (%): --

Financials

  OVAS.OQ Industry Sector
P/E (TTM): -- 82.81 32.74
EPS (TTM): -2.11 -- --
ROI: -65.22 2.00 14.38
ROE: -65.89 3.49 16.08

BRIEF-Ovascience Reports Q1 Loss Per Share Of $0.21

* OVASCIENCE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

May 03 2018

BRIEF-AIGH Investment Partners Reports 6.2 Percent Passive Stake In Ovascience Inc As Of March 28, 2018 ‍​

* AIGH INVESTMENT PARTNERS, L.P. REPORTS 6.2 PERCENT PASSIVE STAKE IN OVASCIENCE INC AS OF MARCH 28, 2018 - SEC FILING‍​ Source text : [https://bit.ly/2pOX7po] Further company coverage:

Mar 29 2018

BRIEF-BML Investment Partners Reports 6.4 Pct Passive Stake In Ovascience

* BML INVESTMENT PARTNERS LP REPORTS 6.4 PERCENT PASSIVE STAKE IN OVASCIENCE INC AS OF MARCH 28 - SEC FILING Source text - https://bit.ly/2J1zaDr Further company coverage:

Mar 28 2018

BRIEF-Ovascience Reports Q4 Loss Per Share $0.24

* OVASCIENCE REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS

Mar 15 2018

BRIEF-OvaScience Says Provided Intrexon Corp With Written Notice Of Termination Of Exclusive Channel Collaboration Agreement, Dated Dec 18, 2013

* OVASCIENCE SAYS PROVIDED INTREXON CORP WITH WRITTEN NOTICE OF TERMINATION OF EXCLUSIVE CHANNEL COLLABORATION AGREEMENT, DATED DEC 18, 2013-SEC FILING

Feb 01 2018

BRIEF-Ovascience Says ‍Reducing Headcount By Approximately 50 Percent​

* OVASCIENCE INC - ‍REDUCING HEADCOUNT BY APPROXIMATELY 50 PERCENT​

Jan 03 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $122.84 +1.39
Pfizer Inc. (PFE.N) $36.51 +0.21
Merck & Co., Inc. (MRK.N) $61.47 +0.29
Sanofi SA (SASY.PA) €69.01 +1.30
Eli Lilly And Co (LLY.N) $85.92 -0.15
Abbott Laboratories (ABT.N) $61.94 +0.19

Earnings vs. Estimates